Ocata Therapeutics Inc (NASDAQ:OCAT)

6.63
Delayed Data
As of 12:10pm ET
 -0.0096 / -0.14%
Today’s Change
4.95
Today|||52-Week Range
12.73
+8.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues39.5K39.5K39.5K39.5K
 
 
 
 
 
Cost of Goods Sold1.0K129.004.5K15.6K
 
 
 
 
 
Depreciation And Amortization29.2K31.0K33.4K45.0K
 
 
 
 
 
 
Operating ExpensesGross Income9.3K8.4K1.6K-21.2K
 
 
 
 
 
General Expenses6.9M5.8M4.9M4.0M
 
 
 
 
 
Research And Development3.3M2.5M2.7M2.4M
 
 
 
 
 
Total Operating Expenses6.9M5.8M4.9M4.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.9M-5.8M-4.9M-4.0M
 
 
 
 
 
Extraordinary Credit742.1K0.001.4M263.8K
 
 
 
 
Extraordinary Charge-5.9M-2.7M-11.9M0.00
 
 
 
 
Interest Expense On Debt272.1K297.0K132.5K69.00
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.3M-8.7M-15.5M-3.7M
 
 
 
 
 
Preferred Dividend0.000.000.00-672.2K
 
 
Net Income-12.3M-8.7M-15.5M-3.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS26.4M28.0M29.6M33.6M
 
 
 
 
 
Shares To Calculate EPS Diluted26.4M28.0M29.6M33.6M
 
 
 
 
 
 
Earnings Per ShareEPS$0.00$0.00-$1.00-$0.13
 
 
 
EPS Diluted-$0.47-$0.31-$1.00-$0.13
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account